LY215840, a high-affinity 5-HT7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 3, 1996, Pages 1560-1566

  Cushing, Daniel J ^a,c   Zgombick, John M ^b   Nelson, David L ^a   Cohen, Marlene L ^a  

^a ELI LILLY AND COMPANY   (United States)

^b H LUNDBECK A S   (Denmark)

^c Astra Merck Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ISOPROPYL 6 METHYLERGOLINE 8 CARBOXYLIC ACID 2 HYDROXY 1 METHYLPROPYL ESTER; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5 CARBAMOYLTRYPTAMINE; 5 METHOXYTRYPTAMINE; ACETYLCHOLINE; AMESERGIDE; BRADYKININ; CALCIMYCIN; ENDOTHELIUM DERIVED RELAXING FACTOR; ERGOLINE DERIVATIVE; N (2 HYDROXYCYCLOPENTYL) 1 ISOPROPYL 6 METHYLERGOLINE 8 CARBOXAMIDE; PENTOBARBITAL; PRAZOSIN; PROSTAGLANDIN F2 ALPHA; SERGOLEXOLE; SEROTONIN; SEROTONIN 2 RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SUMATRIPTAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; BINDING AFFINITY; CELL STRAIN COS1; COMPETITIVE INHIBITION; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DOG; DRUG ANTAGONISM; DRUG POTENCY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; INTRAVENOUS DRUG ADMINISTRATION; ISOLATED ARTERY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; SMOOTH MUSCLE RELAXATION; SYRIAN HAMSTER;

ANIMALS; CORONARY VESSELS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LYSERGIC ACID; MUSCLE, SMOOTH, VASCULAR; RADIOLIGAND ASSAY; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0030425592     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. ARLUNLAKSHANA, O. AND SCHILD, H. D.: Some quantitative uses of drug antagonists. Br. J. Pharmacol. Toxicol. 14: 48-58, 1959.
2. 7) positively linked to adenylate cyclase. J. Biol. Chem. 268: 23422-23426, 1993.
3. 50) of an enzymatic reaction. Biochem. Pharmacol. 22: 3099-3108, 1973.
4. COCKS, T. M. AND ANGUS, J. A.: Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature (Lond.) 305: 627-630, 1983.
5. 2 receptor antagonist, LY53857. Drug Develop. Res. 5: 313-321; 1985.
6. 2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat. J. Pharmacol. Exp. Ther. 227: 327-332, 1983b.
7. 2) receptor antagonist, LY281067. J. Pharmacol. Exp. Ther. 244: 106-112, 1988.
8. 2 receptors and delays occlusion in a rabbit model of thrombosis. J. Pharmacol. Exp. Ther. 261: 202-261, 1992.
9. 2-serotonergic blockade. J. Pharmacol. Exp. Ther. 237: 548-552, 1986.
10. COHEN, R. A., SHEPARD, J. T. AND VANHOUTTE, P. M.: 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries. Am. J. Physiol. (Heart Circ. Physiol. 14): H1077-H1080, 1983a.
11. CUSHING, D. J. AND COHEN, M. L.: Comparison of the serotonin receptors that mediate smooth muscle contraction in canine and porcine coronary artery. J. Pharmacol. Exp. Ther. 261: 856-862, 1992a.
12. CUSHING, D. J. AND COHEN, M. L.: Serotonin-induced relaxation in canine coronary artery smooth muscle. J. Pharmacol. Exp. Ther. 263: 123-129, 1992b.
13. 1D-like receptor. Life Sciences 54:1671-1680, 1994.
14. FOREMAN, M. M., FULLER, R. W., NELSON, D. L., CALLICARO, D. O., KURZ, K. D., MISNER, J. W., GARBRECHT, W. L. AND PARLI, C. J.: Preclinical studies on LY237733, a potent and selective serotonergic antagonist. J. Pharmacol. Exp. Ther. 260: 51-57, 1992.
15. GARBRECHT, W. L., MARZONI, G., WHITTEN, K R. AND COHEN, M. L.: 8(β)-Ergoline-8-carboxylic acid cycloalkyl esteres as serotonin antagoniste: A structureactivity study. J. Med. Chem. 31: 444-448, 1988.
16. HOUSTON, D. S, AND VANHOUTTE, P. M.: Comparison of serotonergic receptor subtypes on the smooth muscle and endothelium of the canine coronary artery. J. Pharmacol. Exp. Ther. 244:1-10, 1988.
17. HOYER, D. AND SCHOEFFTER, P.: 5-HT receptors: Subtypes and second messengers. J. Recept. Res. 11: 197-214, 1991.
18. HUMPHREY, W. R. AND AIKEN, J. W.: Effect of antithrombotic doses of serotonin (5-HT)-receptor antagonists on left circumflex coronary artery (LCX) vasodilator responses in the anesthetized dog. Pharmacologist 33: 218, 1991.
19. 2-receptor affinity. J. Med. Chem., 30: 1823-1826, 1987.
20. 2 receptor activity. J. Med. Chem. 33: 652-656, 1990.
21. MYLECHARANE, E. J.: Mechanisms involved in serotonin-induced vasodilation. Blood Vessels 27: 116-126, 1990.
22. 2) subfamily of receptors: Pharmacological challenges. Med. Chem. Res. 3: 306-316, 1993.
23. TODA, N. AND OKAMURA, T.: Comparison of the response to 5-carboxamidotryptamine and serotonin in isolated human, monkey and dog coronary arteries. J. Pharmacol. Exp. Ther. 253: 676-682, 1990.
24. PARSONS, A. A., RAVAL, P., TILFORD, N. S. AND KAUMANN, A. J.: 5-HT-induced relaxation of sumatriptan precontracted beagle coronary artery. Br. J. Pharmacol. 108: 69, 1993.
25. SAXENA, P. R. AND VILLALON, C. M.: 5-Hydroxytryptamine: A chameleon in the heart. Trends Pharmacol. Sci. 12: 223-227, 1991.
26. 2B receptor: Evidence for species differences. J. Pharmacol. Exp. Ther. 276: 720-727, 1996.
27. 1-like receptors. Eur. J. Pharmacol. 183: 2117-2118, 1990.
28. 1D receptor subtype. Mol. Pharmacol. 40: 1036-1042, 1991.